• Bruno Cutuli, Christine Tunon De Lara, Antoine Arnaud, Philippe Bertheau, Loïc Boulanger, Véronique Boute, Luc Ceugnart, Marie-Pierre Chauvet, Charles Coutant, Patricia De Cremoux, Alain Fourquet, Christophe Hennequin, Audrey Lesieur, Anne Lesur, Laurent Lévy, Anne Vincent-Salomon, Stéphanie Besnard, and Chantal Belorgey.
• Institut du cancer Courlancy, 38, rue de Courlancy, 51100 Reims, France.
• Ann Pathol. 2016 Jun 1; 36 (3): 166-73.

ObjectiveSince the last guidelines published by the French National Cancer Institute (INCa) and the learning society "Société française de sénologie et de pathologie mammaire (SFSPM)" in 2009 about diagnosis and management of ductal carcinoma in situ, new data raised issues about overdiagnosis and its consequences, overtreatment. Therefore, an update was necessary, to provide healthcare professionals up-to-date guidelines and study therapeutic desescalation in particular.MethodsThe clinical practice guidelines development process is based on systematic literature review and critical appraisal by a multidisciplinary experts workgroup. The recommendations are thus based on the best available evidence and experts agreement. Prior to publication, the guidelines are also reviewed by more than 100 independent practitioners in cancer care delivery.ResultsThis article presents French guidelines about MRI and vacuum assisted breast biopsy indications for DCIS diagnosis and the management of low-grade DCIS.Copyright © 2016. Published by Elsevier Masson SAS.

14 keywords...

hide…